Home688136 • SHA
add
Kexing Biopharm Co Ltd
Previous close
¥21.03
Day range
¥20.97 - ¥21.66
Year range
¥13.67 - ¥22.60
Market cap
3.57B CNY
Avg Volume
1.50M
P/E ratio
-
Dividend yield
-
Primary exchange
SHA
Market news
The Independent
35 minutes ago
Dow Jones stock market loses over 1,000 points as recession fears mount
2.58%
2.01%
Financials
Income Statement
Revenue
Net income
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 368.50M | 27.05% |
Operating expense | 709.83M | 95.12% |
Net income | 14.35M | 110.86% |
Net profit margin | 3.90 | 108.56% |
Earnings per share | — | — |
EBITDA | -10.51M | 93.00% |
Effective tax rate | -230.23% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 468.21M | -17.68% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 1.62B | — |
Shares outstanding | 215.68M | — |
Price to book | 2.57 | — |
Return on assets | — | — |
Return on capital | -2.56% | — |
Cash Flow
Net change in cash
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 14.35M | 110.86% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1989
Website
Employees
1,014
